Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Aminobenzoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 18/20 | 0.61 |
| ▸ | CA1 known ✓ | P00915 | 17/20 | 0.61 |
| ▸ | CA4 known ✓ | P22748 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aminobenzoic Acid SCHEMBL28791670 | 0.95 | CA2 (0.56) | CA2CA1CA4KDM4EPOLB | |
| Aminobenzoic Acid SCHEMBL2270342 | 0.95 | CA2 (0.54) | CA2CA1CA4POLBTDP1 | |
| Aminobenzoic Acid SCHEMBL9317385 | 0.95 | CA2 (0.54) | CA2CA1CA4POLBTDP1 | |
| Aminobenzoic Acid SCHEMBL6028845 | 0.95 | CA2 (0.54) | CA2CA1CA4POLBTDP1 | |
| Aminobenzoic Acid SCHEMBL269265 | 0.95 | CA2 (0.54) | CA2CA1CA4POLBTDP1 | |
| Aminobenzoic Acid SCHEMBL11049339 | 0.95 | CA2 (0.54) | CA2CA1CA4POLBTDP1 | |
| Aminobenzoic Acid SCHEMBL3889308 | 0.95 | CA2 (0.54) | CA2CA1CA4POLBTDP1 | |
| Aminobenzoic Acid SCHEMBL9316925 | 0.95 | CA2 (0.54) | CA2CA1CA4POLBTDP1 | |
| Aminobenzoic Acid SCHEMBL10995557 | 0.95 | CA2 (0.54) | CA2CA1CA4POLBTDP1 | |
| Aminobenzoic Acid SCHEMBL233871 | 0.95 | CA2 (0.54) | CA2CA1CA4POLBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 552 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132115-A1 | SUBSTITUTED 3-FLUOROBENZENEPROPANOATE COMPOUND AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF | TIANJIN GUDUI BIO PHARM CO LTD (CN) | 2026-05-14 | — | — | US | claimed |
| EP-4600244-A1 | SUBSTITUTED 3-FLUOROBENZENEPROPANOATE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITIONS, AND USES | Tianjin Gudui Bio-Pharm Co., Ltd. (CN) | 2025-08-13 | — | — | EP | claimed |
| CN-120192247-A | Substituted N- (4-trifluoromethyl) -2-cyano crotonamide compound, preparation method, pharmaceutical composition and application thereof | 天津谷堆生物医药科技有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-120192347-A | Compound for treating oxaliplatin resistant tumors, preparation method, composition and application thereof | 天津谷堆生物医药科技有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-119751984-A | Red phosphorus-based halogen-free flame retardant, and preparation method and application thereof | 安徽长淮新材料有限公司 | 2025-04-04 | — | — | CN | claimed |
| US-12252687-B2 | Recombinant yeast and use thereof | TIANJIN INSTITUTE OF INDUSTRIAL BIOTECHNOLOGY, CHINESE ACADEMY OF SCIENCES (CN) | 2025-03-18 | — | — | US | claimed |
| CN-119463434-A | High-performance antibacterial and detoxifying high polymer material and preparation method thereof | 中氪新能源科技(上海)有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-116459873-B | Olefinically unsaturated compound carbonylation catalyst and preparation method and application thereof | 万华化学集团股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119409907-A | Method for producing polyacrylamide by kneader | 江苏派克斯特纤维素有限公司 | 2025-02-11 | — | — | CN | claimed |
| CN-117904657-A | Carbon material supported alloy electrocatalyst and preparation method and application thereof | 西安热工研究院有限公司 | 2024-04-19 | — | — | CN | claimed |
| WO-2001097862-A2 | STABILISER FOR RADIOPHARMACEUTICALS | AMERSHAM PLC (GB) | 2001-12-27 | — | — | WO | claimed |
| EP-0761818-B1 | Method for producing folic acid | TORAY INDUSTRIES (JP) | 2001-04-04 | — | — | EP | claimed |
| US-5968788-A | CULTURING CANDIDA FAMATA, CANDIDA GUILLIERMONDII, YARROWIA LIPOLYTICA, PICHIA GLUCOZYMA, OR SACCHAROMYCES CEREVISIAE IN MEDIUM WITH GLUCOSE, FRUCTOSE, SUCROSE, OR MALTOSE; RECOVERING AT LEAST 0.3 MILLIGRAMS FOLIC ACID PER LITER MEDIA | TORAY INDUSTRIES, INC. (JP) | 1999-10-19 | — | — | US | claimed |
| CN-1149626-A | Method for producing folic acid | TORAY INDUSTRIES (JP) | 1997-05-14 | — | — | CN | claimed |
| EP-0761818-A1 | Method for producing folic acid | TORAY INDUSTRIES, INC. (JP) | 1997-03-12 | — | — | EP | claimed |
| US-5500668-A | INK JET PRINTING | XEROX CORPORATION (US) | 1996-03-19 | — | — | US | claimed |
| US-5360824-A | Human skin cleansing and wrinkle-reducing cream | BARKER DONALD E (US) | 1994-11-01 | — | — | US | claimed |
| EP-0210751-A2 | Halogen-containing rubbers and their manufacture | MARINE MAGNESIUM COMPANY (US) | 1987-02-04 | — | — | EP | claimed |
| US-4632954-A | WITH AMINOCARBOXY COMPOUNDS | CALGON CORPORATION (US) | 1986-12-30 | — | — | US | claimed |
| US-4112221-A | HEATING A 2',3'-O-SULFINYL-8-OXYPURINE | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1978-09-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132115-A1 | SUBSTITUTED 3-FLUOROBENZENEPROPANOATE COMPOUND AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF | BACE1, IL1B, CYP11B1 | CA2 1711/4885CA1 283/4885CA4 521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.